Literature DB >> 27980746

Inflammatory myofibroblastic pancreas tumor: a case report.

Muharrem Battal1, Kinyas Kartal1, Deniz Tuncel2, Ozgur Bostanci1.   

Abstract

Inflammatory myofibroblastic tumor (IMT) histologically characterized by fibroblastic and myofibroblastic proliferation with inflammatory infiltrate. The therapy adopted was Whipple's pancreaticoduodenectomy with a histological diagnosis of the inflammatory myofibroblastic tumor. The disease that should be considered as the differential diagnosis is pancreatic cancer. The diagnosis and treatment of IMT is surgical resection.

Entities:  

Keywords:  Inflammatory tumor; Whipple procedure; pancreatic mass; surgical resection

Year:  2016        PMID: 27980746      PMCID: PMC5134138          DOI: 10.1002/ccr3.717

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


Introduction

Inflammatory myofibroblastic tumor (IMT), also known as inflammatory pseudotumor, is a generic term applied to a heterogeneous group of lesions occurring in various organs, which is histologically characterized by fibroblastic and myofibroblastic proliferation with inflammatory infiltrate 1. Inflammatory myofibroblastic tumor was first described in the lung, where it was considered a postinflammatory condition rather than a malignancy process 2, 3. Recent data suggest that IMT can be detected in various anatomic regions, and organs including liver, gastrointestinal tract, abdominal soft tissue, lymph node, spleen, and extremely rare in the pancreas. In this study, we reported a patient who admitted to the emergency department with signs of acute abdomen. Further investigations diagnosed as IMT caused from pancreatic head mass.

Case Report

A 46‐year‐old male, without any known health problems, admitted to our hospital with signs and symptoms of acute abdomen. There were no any biliary or gastrointestinal obstruction symptoms. On physical examination, there was diffuse abdominal pain and tenderness. Laboratory analyses have shown that it was acute pancreatitis. The amylase level was 224 U/L, pancreatic amylase level was 597 U/L, GGT was 904 U/L, and WBC was 11.5, respectively. CA19‐9 level was 110.80 U/mL, while all the other tumor markers were at normal levels. Abdominal ultrasound revealed a 129 × 70 mm mass in the head of the pancreas. Abdominal magnetic resonance imaging (MRI) was performed. MRI findings showed that there was a 92 × 84 mm mass with solid and cystic components in the pancreas uncinate process. Multiple lymph nodes, the largest of which was 16 × 10 mm in size, were detected around the pancreatic mass (Fig. 1).
Figure 1

Magnetic resonance imaging sections revealed a heterogeneous pancreatic mass measuring 92 × 84 mm mass with solid and cystic components in the pancreas uncinate process.

Magnetic resonance imaging sections revealed a heterogeneous pancreatic mass measuring 92 × 84 mm mass with solid and cystic components in the pancreas uncinate process. The patient's oral intake was stopped, and intravenous fluid therapy was started. During the medical follow‐up, the abdominal pain decreased and laboratory findings fell to normal levels. After 4 weeks of acute pancreatitis episode, patient was operated. During laparotomy, the mass, which was associated with multiple fibrous adhesions to the surrounding tissue, was resected by pancreaticoduodenectomy (Whipple procedure). Eight days after the surgery, the patient was discharged in good health with no complication. Macroscopically, the tumor was 8 × 6 × 5 cm mass, poorly demarcated from the normal pancreatic parenchyma. The pancreatic duct was intact, and the tumor was as an elastic, hard, solid mass with a yellowish and whitish cut surface (Fig. 2).
Figure 2

Macroscopic view of the resected material.

Macroscopic view of the resected material. Histologically, there was chronic inflammation and edema around the ampulla of Vater. In some sections of the specimen, fibrous spindle cells were observed in myxoid stroma of the pancreas. The immunohistochemical studies showed a nonspecific staining with S100, SMA, Desmin, and C‐kit, while staining with smooth muscle actin was focally positive. Ki‐67 proliferation index was 2% (Fig. 3).
Figure 3

(A) Bland spindle‐shaped cells admixed with lymphocyte predominant inflammatory infiltrate on the left side and uniform pancreatic tissue on the right. H&E, X200, (B) Bland spindle‐shaped cells admixed with lymphocyte predominant inflammatory infiltrate. H&E, X400.

(A) Bland spindle‐shaped cells admixed with lymphocyte predominant inflammatory infiltrate on the left side and uniform pancreatic tissue on the right. H&E, X200, (B) Bland spindle‐shaped cells admixed with lymphocyte predominant inflammatory infiltrate. H&E, X400. The lesion was composed of bland spindle‐shaped cells arranged in a storiform pattern. Lymphohistiocytic infiltrate was associated with the lesion in scant foci. Atypical mitotic figures, hyperchromasia, and cytological atypia were not present.

Discussion

Various names have been used to describe IMT, such as plasma cell granuloma, plasma cell pseudotumor, inflammatory pseudotumor, inflammatory fibroxanthoma, and histiocytoma 4. IMTs are classified as tumors of intermediate biological potential by the most recent World Health Organization classification, due to a tendency for local recurrence and a small risk of distant metastasis 5. Although IMT has been seen in various organs, it is extremely rare to be seen in the pancreas. We find only 29 patients with IMT arising from the pancreas reported in the English language scientific literature 6, 7, 8, 9. While the youngest patient in the literature was 6 months old, the oldest patient was 64 years of age (mean age: 36 years). Our patient was 46 years old, and this was consistent with the medical literature. In the other IMT cases, the patients were usually asymptomatic and diagnosed incidentally. According to our search in the medical literature, our case is the second IMT case that reported who has been diagnosed after signs and symptoms of acute pancreatitis 10. Laboratory findings of IMT were variable and nonspecific to the disease 11. The most common symptom of IMT is a mass discovered incidentally by radiographic investigations for other reasons. Therefore, IMT can be easily diagnosed as pancreatic cancer. Other symptoms could be abdominal pain (45%), jaundice (45%), weight loss (24%), and palpable abdominal mass (21%) 8, 12. Inflammatory myofibroblastic tumor is most commonly mistaken for a pancreatic cancer clinically and radiologically. Definitive diagnosis was made only by extensive histological examination 13. Therefore, complete surgical resection and pathologic evaluation of the tumor are necessary to confirm the diagnosis 10. In the management of IMT, surgical excision should be the primary choice to obtain a definitive diagnosis and to relieve symptoms. Careful follow‐up after surgery is also necessary. According to the review of Coffin, the recurrence rate was approximately 25% after the surgery 14, 15.

Conclusion

In this study, we aimed to explain a rare case, who presented to the emergency department with the findings of acute pancreatitis, and the further examinations revealed IMT. Inflammatory myofibroblastic tumor of the pancreas is a rare, benign tumor of the hepatobiliary system. The first disease, which should be considered in the differential diagnosis, is pancreatic cancer. According to the current medical literature, the primary choice in the diagnosis, and treatment of IMT, as well, is surgical resection.

Conflict of Interest

None of the authors has a conflict of interest with any institution or organization.
  14 in total

1.  Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor.

Authors:  W O UMIKER; L IVERSON
Journal:  J Thorac Surg       Date:  1954-07

2.  Inflammatory myofibroblastic tumour of the pancreas.

Authors:  Adrian Sim; Mark W Lee; Gia-Khanh Nguyen
Journal:  Can J Surg       Date:  2008-02       Impact factor: 2.089

3.  Plasma cell granuloma of the pancreas: CT findings.

Authors:  S D Qanadli; F d'Anthouard; J P Cugnec; G Frija
Journal:  J Comput Assist Tomogr       Date:  1997 Sep-Oct       Impact factor: 1.826

4.  Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis.

Authors:  V Wreesmann; C H van Eijck; D C Naus; M L van Velthuysen; J Jeekel; W J Mooi
Journal:  Histopathology       Date:  2001-02       Impact factor: 5.087

5.  Inflammatory myofibroblastic tumor (IMT) of the pancreas.

Authors:  Hiroshi Yamamoto; Kazuo Watanabe; Matsuo Nagata; Kentaro Tasaki; Ichiro Honda; Satoshi Watanabe; Hiroaki Soda; Toshinao Takenouti
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

6.  Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study.

Authors:  Hidetaka Yamamoto; Hiroshi Yamaguchi; Shinichi Aishima; Yoshinao Oda; Kenichi Kohashi; Yumi Oshiro; Masazumi Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  2009-09       Impact factor: 6.394

7.  Primary mesenchymal tumors of the pancreas: single-center experience over 16 years.

Authors:  Joo Young Kim; Joon Seon Song; Hosub Park; Jae Ho Byun; Ki-Byung Song; Kyu-Pyo Kim; Song Cheol Kim; Seung-Mo Hong
Journal:  Pancreas       Date:  2014-08       Impact factor: 3.327

Review 8.  Inflammatory myofibroblastic tumor presenting as a pancreatic mass: a case report and review of the literature.

Authors:  Surakit Pungpapong; Xochi J Geiger; Massimo Raimondo
Journal:  JOP       Date:  2004-09-10

Review 9.  Inflammatory myofibroblastic tumours: where are we now?

Authors:  B C Gleason; J L Hornick
Journal:  J Clin Pathol       Date:  2007-10-15       Impact factor: 3.411

10.  Inflammatory myofibroblastic tumor of the pancreas--a case report.

Authors:  Ender Dulundu; Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  Biosci Trends       Date:  2007-12       Impact factor: 2.400

View more
  3 in total

1.  Inflammatory myofibroblastic tumors arising from pancreas head and peri-splenic area mimicking a malignancy.

Authors:  Eun Jeong Jang; Kwan Woo Kim; Sung Hwa Kang; Min Gyoung Pak; Song Hee Han
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-05-31

2.  A Pancreatic Inflammatory Myofibroblastic Tumor with Spontaneous Remission: A Case Report with a Literature Review.

Authors:  Hiroyuki Matsubayashi; Katsuhiko Uesaka; Keiko Sasaki; Seitaro Shimada; Kazunori Takada; Hirotoshi Ishiwatari; Hiroyuki Ono
Journal:  Diagnostics (Basel)       Date:  2019-10-17

3.  Immunoglobulin G4-Negative Inflammatory Pseudotumors of the Pancreas.

Authors:  Matthew T Geiselmann; Daniel J Acampa; Joshua Melamed; Farzana Arif; Kazuaki Takabe; Eric Seitelman; Rajiv Datta; Ganesh Gunasekaran; Hideo Takahashi
Journal:  World J Oncol       Date:  2021-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.